JP2023536497A5 - - Google Patents

Info

Publication number
JP2023536497A5
JP2023536497A5 JP2023507480A JP2023507480A JP2023536497A5 JP 2023536497 A5 JP2023536497 A5 JP 2023536497A5 JP 2023507480 A JP2023507480 A JP 2023507480A JP 2023507480 A JP2023507480 A JP 2023507480A JP 2023536497 A5 JP2023536497 A5 JP 2023536497A5
Authority
JP
Japan
Prior art keywords
disease
antigen peptide
dementia
pharmaceutical formulation
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023507480A
Other languages
English (en)
Japanese (ja)
Other versions
JP7898188B2 (ja
JP2023536497A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/071778 external-priority patent/WO2022029181A1/en
Publication of JP2023536497A publication Critical patent/JP2023536497A/ja
Publication of JP2023536497A5 publication Critical patent/JP2023536497A5/ja
Application granted granted Critical
Publication of JP7898188B2 publication Critical patent/JP7898188B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023507480A 2020-08-04 2021-08-04 免疫原性化合物 Active JP7898188B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20189425 2020-08-04
EP20189425.0 2020-08-04
PCT/EP2021/071778 WO2022029181A1 (en) 2020-08-04 2021-08-04 Immunogenic compounds

Publications (3)

Publication Number Publication Date
JP2023536497A JP2023536497A (ja) 2023-08-25
JP2023536497A5 true JP2023536497A5 (cg-RX-API-DMAC7.html) 2024-08-13
JP7898188B2 JP7898188B2 (ja) 2026-07-31

Family

ID=72178339

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507480A Active JP7898188B2 (ja) 2020-08-04 2021-08-04 免疫原性化合物

Country Status (10)

Country Link
US (1) US20230287050A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192493A1 (cg-RX-API-DMAC7.html)
JP (1) JP7898188B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230044524A (cg-RX-API-DMAC7.html)
CN (1) CN116261464A (cg-RX-API-DMAC7.html)
AU (1) AU2021322080A1 (cg-RX-API-DMAC7.html)
CA (1) CA3185563A1 (cg-RX-API-DMAC7.html)
IL (1) IL300364A (cg-RX-API-DMAC7.html)
MX (1) MX2023001483A (cg-RX-API-DMAC7.html)
WO (1) WO2022029181A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL314865A (en) * 2022-02-09 2024-10-01 Ac Immune Sa Anti-alpha-synuclein therapeutic vaccines
KR20250135293A (ko) 2023-01-26 2025-09-12 에이씨 이뮨 에스에이 리포좀 구조체
WO2025109524A1 (en) 2023-11-22 2025-05-30 Ac Immune Sa Assays and methods for assessing vaccine preparations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2361928T3 (en) 2003-05-19 2017-07-03 Prothena Biosciences Ltd Truncated fragments of alpha synuclein in Lewy body disease
US20050203010A1 (en) 2003-11-14 2005-09-15 Atgen Co., Ltd. Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
AT506535B1 (de) * 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
AT508638B1 (de) 2009-08-21 2011-08-15 Affiris Ag Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien
PL2723379T3 (pl) * 2011-06-23 2019-05-31 Biogen Int Neuroscience Gmbh Cząsteczki wiążące przeciwko alfa-synukleinie
CA3003943A1 (en) 2015-11-03 2017-05-11 Affiris Ag Method for vaccination against a self-antigen in a human patient
JP7136790B2 (ja) * 2017-02-17 2022-09-13 ブリストル-マイヤーズ スクイブ カンパニー アルファ-シヌクレインに対する抗体およびその使用
JP2021508672A (ja) * 2017-06-16 2021-03-11 ユナイテッド ニューロサイエンスUnited Neuroscience シヌクレイノパチーの治療のためのアルファ−シヌクレインタンパク質のc末端からのペプチド免疫原及びその製剤
WO2021055881A1 (en) * 2019-09-20 2021-03-25 Denali Therapeutics Inc. Anti-alpha-synuclein antibodies and methods of use thereof

Similar Documents

Publication Publication Date Title
RU2011100125A (ru) Соединения для лечения амилоидозов
RU2011100126A (ru) Применение мимотопов для лечения бетта-амилоидозов
RU2007145052A (ru) Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера
KR102869640B1 (ko) 항-aveta 치료적 백신
HUE031860T2 (en) PCSK9 vaccine
ES2587962T3 (es) Conjugados de albúmina-péptido amiloide y usos de los mismos
HK1249859A1 (zh) Pcsk9肽疫苗
TW201345927A (zh) 組成物
CN1917898B (zh) 用于治疗间质肺部感染的血管活性肠肽的生物活性物质
US20250152684A1 (en) Anti-Alpha-Synuclein Therapeutic Vaccines
US20230287050A1 (en) Immunogenic Compounds
JP2025506472A5 (cg-RX-API-DMAC7.html)
CN107998386A (zh) 基于补体组分c5a的疫苗
CN118660717A (zh) 抗α-突触核蛋白的治疗性疫苗
EA051687B1 (ru) Терапевтические вакцины против альфа-синуклеина
JP2012510794A5 (cg-RX-API-DMAC7.html)
EP2532359A1 (en) CETP fragments
WO2024156908A1 (en) Liposomal construct
JP2024538615A5 (cg-RX-API-DMAC7.html)
TW201348264A (zh) 組成物
HK1170248A (en) Immunogenes peptide